SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer

Borghaei, H. ; de Marinis, F. ; Dumoulin, D. ; Reynolds, C. ; Theelen, W.S.M.E. ; Percent, I. ; Gutierrez Calderon, V. ; Johnson, M.L. ; Madroszyk-Flandin, A. ; Garon, E.B. ; He, K. ; Planchard, D. ; Reck, M. ; Popat, S. ; Herbst, R.S. ; Leal, T.A. ; Shazer, R.L. ; Yan, X. ; Harrigan, R. ; Peters, S.

Annals of oncology, 2024-01, Vol.35 (1), p.66-76 [Periódico revisado por pares]

England: Elsevier Ltd

Sem texto completo